Iterum Therapeutics GAAP EPS of -$0.30 beats by $0.15 (NASDAQ:ITRM)
Iterum Therapeutics press release (NASDAQ:ITRM): Q2 GAAP EPS of -$0.30 beats by $0.15. Cash, cash equivalents and short-term investments were…
TG Therapeutics secures $250M debt financing (NYSE:OWL)
Blue Owl Capital (NYSE:OWL) and HealthCare Royalty have entered into a $250M term loan facility with biopharmaceutical company TG Therapeutics…
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press…
Nektar Therapeutics director sells $23,400 in company stock By Investing.com
SAN FRANCISCO, CA – Nektar Therapeutics (NASDAQ:) director, Robert Chess, has sold a total of 19,500 shares of company stock,…
Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders
Article contentSAN DIEGO & SHANGHAI — Sirius Therapeutics, announced it has dosed the first subject in a Phase 1, first-in-human…
Andreessen Co-Leads $200 Million Investment in Biotech Startup Genesis Therapeutics
Venture firm Andreessen Horowitz has co-led a $200 million investment in Genesis Therapeutics, a biotechnology startup that uses artificial intelligence…
Horizon Therapeutics, Activision among best bets for M&A deals to close
Parradee Kietsirikul Amgen's (AMGN) planned $28 billion purchase of Horizon Therapeutics (NASDAQ:HZNP) and Microsoft's $69 billion acquisition of video game…
Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment
(Reuters) - Nektar Therapeutics on Monday sued Eli Lilly, accusing the drugmaker of undermining the prospects for Rezpeg, which Nektar…
Checkpoint Therapeutics Announces 3.24M Share Offering at $3.09/sh By Investing.com
Checkpoint Therapeutics (CKPT) Announces 3.24M Share Offering at $3.09/sh Checkpoint Therapeutics (NASDAQ:), Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and…